KORU Medical Systems Receives FDA 510(k) Clearance for the Use of the FREEDOM60® with Two Additional SCIg Drugs Dec 21, 2021 4:01pm EST
KORU Medical Announces FDA Clearance for Delivery of Hizentra® Prefilled Syringes Nov 10, 2021 4:00pm EST
KORU Medical Systems to Report Third Quarter 2021 Financial Results on November 10, 2021 Oct 27, 2021 4:01pm EDT
KORU Medical Appoints Chris Pazdan as Vice President of Quality Assurance and Regulatory Affairs Oct 26, 2021 7:00am EDT
